期刊文献+

吉非替尼联合卡培他滨三线治疗晚期结肠癌1例 被引量:3

Gefitinib Combined with Capecitabine as A Third-line Treatment for Advanced Colon Cancer: Report of A Case
下载PDF
导出
摘要 病例:患者女,51岁,2007年6月22日于外院行体检时查腹部CT示“肝占位”,结肠镜病理示“结肠腺癌”。
出处 《胃肠病学》 2012年第10期639-640,共2页 Chinese Journal of Gastroenterology
关键词 结肠肿瘤 吉非替尼 卡培他滨 肿瘤转移 治疗 Colonic Neoplasms Gefilinib Capecitabine Neoplasm Metastasis Therapy
  • 相关文献

参考文献9

  • 1Tol J, Koopman M, Cats A, et a1. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer [JJ. N Engl J Med, 2009, 360 (6) : 563-572.
  • 2Bitossi R, Sculli CM, Tampellini M, et aI. Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients [ J ] . Anticancer Res, 2008, 28 (5B) : 3055-3060.
  • 3Gholam D, Giacchetti S, Brezault-Bonnet C, et al. Chro?nomodulated irinotecan, oxaliplatin, and leucovorin?modulated 5-fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer [ J J . Oncologist, 2006 , 11 (10): 1072-1080.
  • 4Ardavanis AS, Ioannidis GN, Orphanos GS, et aI. Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer [J]. Anticancer Res, 2006, 26 (2B) : 1669-1672.
  • 5Van Cutsem E, Kohne CH, Hitre E, et a1. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer [J]. N Engl J Med, 2009, 360 (14) : 1408-1417.
  • 6Huang S, Armstrong EA, Benavente S, et aI. Dual-agent molecular targeting of the epidermal growth factor receptor ( EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor [ J ] . Cancer Res, 2004, 64 (15): 5355-5362.
  • 7Chau I, Cunningham D, Hickish T, et a1. Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I - IT study [J]. Ann Oncol, 2007, 18 (4) : 730-737.
  • 8Kuo T, Cho CD, Halsey J, et a1. Phase IT study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancerj L], J Clio Oncol , 2005, 23 (24): 5613-5619.
  • 9Waddell T, Gollins S, Soe W, et aI. Phase IT study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study [J]. Cancer Chemother Pharmacol , 2011, 67 (5): 1111-1117.

同被引文献24

  • 1朱辉.希罗达治疗结肠癌的毒副反应分析与护理[J].医学信息(医学与计算机应用),2016,29(26):164-165. 被引量:1
  • 2Ribeiro SM,Braga CB,Peria FM,et al.Effect of Zinc Supplementation on Antioxidant Defenses and Oxidative Stress Markers in Patients Undergoing Chemotherapy for Colorectal Cancer:a Placebo-Controlled,Prospective Randomized Trial[J].Biol Trace Elem Res,2015,1(12):118-120.
  • 3Al-Shamsi HO,Kee BK,Tetzlaff MT,et al.Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer[J].J Gastrointest Oncol,2015,6(3):40-43.
  • 4Simunovic MR,DeNardi FG,Coates AJ,et al.Product analysis and initial reliability testing of the total mesorectal excision-quality assessment instrument[J].Ann Surg Oncol,2014,21(7):2274-2279.
  • 5Vedat Bayoglu I,Yildiz I,Varol U,et al.Comparison of first-line bevacizumab in combination with mFOLFOX6or XELOX in metastatic colorectal cancer[J].J BUON,2015,20(2):460-467.
  • 6Bongiovanni D,Bassetti B,Kupatt C,et al.Role of bone marrow-derived CD133+stem cells in cardiac regeneration:from experimental to clinical trials[J].G Ital Cardiol(Rome),2014,15(6):355-362.
  • 7Hansen M,Nyby S,Eifer M?倠ller J,et al.Intracoronary Injection of CD34-Cells in Chronic Ischemic Heart Failure:7Years Follow-Up of the DanCell Study[J].Cardiology,2014,129(2):69-74.
  • 8孙娜,田菲.扶正合剂联合希罗达治疗结肠癌30例[J].江西中医药,2010,41(1):37-38. 被引量:3
  • 9庄志祥,沈旭东,沈丽琴,张玉松,陆玉峰,初学.雷替曲塞与5-氟尿嘧啶联合奥沙利铂治疗晚期结直肠癌的疗效比较[J].苏州大学学报(医学版),2010,30(3):573-576. 被引量:46
  • 10黄江远.晚期结肠癌患者姑息性支架置入的临床意义和疗效[J].临床和实验医学杂志,2011,10(16):1278-1279. 被引量:1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部